Literature DB >> 2500247

Safety of the nonionic contrast medium omnipaque in coronary angiography.

K Levorstad1, K Vatne, U Brodahl, B Laake, S Simonsen, T Aakhus.   

Abstract

The low osmolar nonionic contrast medium Omnipaque was used in 5,339 consecutive coronary angiographies and serious complications were registered. Myocardial infarction occurred in 4 patients, of whom 2 died, and ventricular fibrillation in 1. Cerebral embolism occurred in 11 patients, all of whom survived. The results are compared with those of previous series of coronary angiography with high osmolar ionic media. It is concluded that use of the nonionic medium Omnipaque resulted in a significant reduction of the frequency of serious complications.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500247     DOI: 10.1007/bf02577398

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  14 in total

1.  The new contrast agents: a perspective.

Authors:  M A Bettmann
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

2.  Incidence of fibrillation with isotonic contrast media for intra-arterial coronary digital subtraction angiography.

Authors:  T W Morris; K Hayakawa; L G Sahler; S Ekholm
Journal:  Diagn Imaging Clin Med       Date:  1986

3.  Complication rates of selective percutaneous transfemoral coronary arteriography. A review of 1094 consecutive examinations.

Authors:  S Nitter-Hauge; I Enge
Journal:  Acta Med Scand       Date:  1976

4.  How safe is the coronary angiogram?

Authors:  D F Adams
Journal:  Cardiovasc Intervent Radiol       Date:  1982       Impact factor: 2.740

5.  Metrizamide compared with metrizoate in cardioangiography in high-risk patients with coronary artery disease.

Authors:  K Levorstad; K Vatne; S Simonsen; S Nitter-Hauge; E Andrew
Journal:  Acta Radiol Diagn (Stockh)       Date:  1985 Jul-Aug

6.  Incidence of ventricular fibrillation during coronary arteriography in the rabbit. A comparative study of isotonic ioxaglate and iohexol.

Authors:  A M Donadieu; C Hartl; A Cardinal; B Bonnemain
Journal:  Invest Radiol       Date:  1987-02       Impact factor: 6.016

7.  New angiographic agents with less fibrillatory propensity.

Authors:  G L Wolf; C S Mulry; K Kilzer; P A Laski
Journal:  Invest Radiol       Date:  1981 Jul-Aug       Impact factor: 6.016

8.  Amipaque: a new contrast medium in coronary angiography. Report of a double-blind study in man.

Authors:  I Enge; S Nitter-Hauge; E Andrew; K Levorstad
Journal:  Radiology       Date:  1977-11       Impact factor: 11.105

9.  Cardiotolerance of iohexol. Survey of experimental evidence.

Authors:  C B Higgins
Journal:  Invest Radiol       Date:  1985 Jan-Feb       Impact factor: 6.016

10.  Summary of U.S. and European intravascular experience with iohexol based on the clinical trial program.

Authors:  K Dahlstrom; D D Shaw; W Clauss; E Andrew; K Sveen
Journal:  Invest Radiol       Date:  1985 Jan-Feb       Impact factor: 6.016

View more
  5 in total

Review 1.  Clinical and economic factors in the selection of low-osmolality contrast media.

Authors:  W H Matthai
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

2.  Unsuccessful pericardiocentesis for cardiac tamponade during angiocardiography with nonionic contrast material.

Authors:  J Calabuig; S Mejía; J Cabanero; S Crisóstomo; C Navarro; D Martínez Caro
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Jul-Aug       Impact factor: 2.740

3.  Iopamidol in cardioangiography: a retrospective, multicenter study. Part I. Adult patients.

Authors:  L Ballerini; F Barbaresi; G Binaghi; C Cernigliaro; R Chioin; R Fattori; L Inglese; G Invernizzi; S Leto di Priolo; F Passoni
Journal:  Int J Card Imaging       Date:  1992

4.  A double-blind CT study comparing the safety and efficacy of iopentol and ioxaglate in paediatric patients.

Authors:  N Sayegh; C Porée; J Baraton; K Skinningsrud; C Nantois; D Lallemand
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

5.  Tender Endothelium Syndrome: Combination of Hypotension, Bradycardia, Contrast Induced Chest Pain, and Microvascular Angina.

Authors:  Shivesh Goberdhan; Soon Kwang Chiew; Jaffer Syed
Journal:  Case Rep Cardiol       Date:  2016-02-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.